Literature DB >> 15871729

Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile.

E David Crawford1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15871729     DOI： 10.1111/j.1464-410X.2005.05484.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  4 in total

Review 1.  Acute urinary retention: who is at risk and how best to manage it?

Authors:  Anand Patel; Christopher Chapple
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

Review 2.  Benign prostatic hyperplasia: treatment in primary care.

Authors:  Anand K Patel; Christopher R Chapple
Journal:  BMJ       Date:  2006-09-09

Review 3.  Treatment of benign prostatic hyperplasia in patients with cardiovascular disease.

Authors:  Vincent M Santillo; Franklin C Lowe
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  A Randomized, Open-Label, Comparative Study of Efficacy and Safety of Tolterodine Combined with Tamsulosin or Doxazosin in Patients with Benign Prostatic Hyperplasia.

Authors:  Yanwei Cao; Yonghua Wang; Lei Guo; Xuecheng Yang; Tao Chen; Haitao Niu
Journal:  Med Sci Monit       Date:  2016-06-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.